131 related articles for article (PubMed ID: 33385499)
1. Bombesin, endothelin, neurotensin and pituitary adenylate cyclase activating polypeptide cause tyrosine phosphorylation of receptor tyrosine kinases.
Moody TW; Ramos-Alvarez I; Jensen RT
Peptides; 2021 Mar; 137():170480. PubMed ID: 33385499
[TBL] [Abstract][Full Text] [Related]
2. The G Protein-Coupled Receptor PAC1 Regulates Transactivation of the Receptor Tyrosine Kinase HER3.
Moody TW; Lee L; Jensen RT
J Mol Neurosci; 2021 Aug; 71(8):1589-1597. PubMed ID: 32964398
[TBL] [Abstract][Full Text] [Related]
3. Pituitary adenylate cyclase-activating polypeptide causes tyrosine phosphorylation of the epidermal growth factor receptor in lung cancer cells.
Moody TW; Osefo N; Nuche-Berenguer B; Ridnour L; Wink D; Jensen RT
J Pharmacol Exp Ther; 2012 Jun; 341(3):873-81. PubMed ID: 22389426
[TBL] [Abstract][Full Text] [Related]
4. Adding of neurotensin to non-small cell lung cancer cells increases tyrosine phosphorylation of HER3.
Moody TW; Ramos-Alvarez I; Jensen RT
Peptides; 2022 Oct; 156():170858. PubMed ID: 35932909
[TBL] [Abstract][Full Text] [Related]
5. Neurotensin (NTS) and its receptor (NTSR1) causes EGFR, HER2 and HER3 over-expression and their autocrine/paracrine activation in lung tumors, confirming responsiveness to erlotinib.
Younes M; Wu Z; Dupouy S; Lupo AM; Mourra N; Takahashi T; Fléjou JF; Trédaniel J; Régnard JF; Damotte D; Alifano M; Forgez P
Oncotarget; 2014 Sep; 5(18):8252-69. PubMed ID: 25249545
[TBL] [Abstract][Full Text] [Related]
6. Neuropeptide bombesin receptor activation stimulates growth of lung cancer cells through HER3 with a MAPK-dependent mechanism.
Lee L; Ramos-Alvarez I; Moody TW; Mantey SA; Jensen RT
Biochim Biophys Acta Mol Cell Res; 2020 Apr; 1867(4):118625. PubMed ID: 31862538
[TBL] [Abstract][Full Text] [Related]
7. EGFR Transactivation by Peptide G Protein-Coupled Receptors in Cancer.
Moody TW; Nuche-Berenguer B; Nakamura T; Jensen RT
Curr Drug Targets; 2016; 17(5):520-8. PubMed ID: 25563590
[TBL] [Abstract][Full Text] [Related]
8. Peptide G-Protein-Coupled Receptors and ErbB Receptor Tyrosine Kinases in Cancer.
Moody TW; Ramos-Alvarez I; Jensen RT
Biology (Basel); 2023 Jul; 12(7):. PubMed ID: 37508387
[TBL] [Abstract][Full Text] [Related]
9. PYK-2 is tyrosine phosphorylated after activation of pituitary adenylate cyclase activating polypeptide receptors in lung cancer cells.
Moody TW; Di Florio A; Jensen RT
J Mol Neurosci; 2012 Nov; 48(3):660-6. PubMed ID: 22581436
[TBL] [Abstract][Full Text] [Related]
10. Pituitary adenylate cyclase-activating polypeptide (PACAP)/PAC1HOP1 receptor activation coordinates multiple neurotrophic signaling pathways: Akt activation through phosphatidylinositol 3-kinase gamma and vesicle endocytosis for neuronal survival.
May V; Lutz E; MacKenzie C; Schutz KC; Dozark K; Braas KM
J Biol Chem; 2010 Mar; 285(13):9749-9761. PubMed ID: 20093365
[TBL] [Abstract][Full Text] [Related]
11. Neuropeptide G Protein-Coupled Receptors as Oncotargets.
Moody TW; Ramos-Alvarez I; Jensen RT
Front Endocrinol (Lausanne); 2018; 9():345. PubMed ID: 30008698
[TBL] [Abstract][Full Text] [Related]
12. Direct cAMP signaling through G-protein-coupled receptors mediates growth cone attraction induced by pituitary adenylate cyclase-activating polypeptide.
Guirland C; Buck KB; Gibney JA; DiCicco-Bloom E; Zheng JQ
J Neurosci; 2003 Mar; 23(6):2274-83. PubMed ID: 12657686
[TBL] [Abstract][Full Text] [Related]
13. Role of protein kinase C and epidermal growth factor receptor signalling in growth stimulation by neurotensin in colon carcinoma cells.
Müller KM; Tveteraas IH; Aasrum M; Ødegård J; Dawood M; Dajani O; Christoffersen T; Sandnes DL
BMC Cancer; 2011 Oct; 11():421. PubMed ID: 21961726
[TBL] [Abstract][Full Text] [Related]
14. Activation of EGFR, HER2 and HER3 by neurotensin/neurotensin receptor 1 renders breast tumors aggressive yet highly responsive to lapatinib and metformin in mice.
Dupouy S; Doan VK; Wu Z; Mourra N; Liu J; De Wever O; Llorca FP; Cayre A; Kouchkar A; Gompel A; Forgez P
Oncotarget; 2014 Sep; 5(18):8235-51. PubMed ID: 25249538
[TBL] [Abstract][Full Text] [Related]
15. The neuropeptide pituitary adenylate cyclase activating protein stimulates human monocytes by transactivation of the Trk/NGF pathway.
El Zein N; Badran BM; Sariban E
Cell Signal; 2007 Jan; 19(1):152-62. PubMed ID: 16914291
[TBL] [Abstract][Full Text] [Related]
16. Neurotensin receptors regulate transactivation of the EGFR and HER2 in a reactive oxygen species-dependent manner.
Moody TW; Lee L; Ramos-Alvarez I; Jensen RT
Eur J Pharmacol; 2019 Dec; 865():172735. PubMed ID: 31614143
[TBL] [Abstract][Full Text] [Related]
17. Gastrointestinal peptide signalling in health and disease.
Rozengurt E; Guha S; Sinnett-Smith J
Eur J Surg Suppl; 2002; (587):23-38. PubMed ID: 16144198
[TBL] [Abstract][Full Text] [Related]
18. Molecular mechanisms involved in the protective effect of pituitary adenylate cyclase-activating polypeptide in an in vitro model of amyotrophic lateral sclerosis.
Maugeri G; D'Amico AG; Rasà DM; Federico C; Saccone S; Morello G; La Cognata V; Cavallaro S; D'Agata V
J Cell Physiol; 2019 Apr; 234(4):5203-5214. PubMed ID: 30238989
[TBL] [Abstract][Full Text] [Related]
19. Endothelin causes transactivation of the EGFR and HER2 in non-small cell lung cancer cells.
Moody TW; Ramos-Alvarez I; Moreno P; Mantey SA; Ridnour L; Wink D; Jensen RT
Peptides; 2017 Apr; 90():90-99. PubMed ID: 28153500
[TBL] [Abstract][Full Text] [Related]
20. Bombesin receptor subtype-3 agonists stimulate the growth of lung cancer cells and increase EGF receptor tyrosine phosphorylation.
Moody TW; Sancho V; di Florio A; Nuche-Berenguer B; Mantey S; Jensen RT
Peptides; 2011 Aug; 32(8):1677-84. PubMed ID: 21712056
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
